DAVID OPHOFF: Open Payments
NPI 1821379132 · GRAND RAPIDS, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,107 in 26 payments from 3 companies in 2025. Trend: 2023 $68 · 2024 $2,846 · 2025 $4,107
Consulting: $2,250Travel & lodging: $1,177Food & beverage: $638Education: $41
| Company | Payments | Amount |
|---|---|---|
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 21 | $3,931 |
| Novo Nordisk Inc | 2 | $134 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $41 |
Products named: TRULANCE, XIFAXAN, Wegovy, EOHILIA.
Industry payments across MI — which companies pay providers there.
